Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D003640:Dealkylation; D003913:Dextroamphetamine / Q000494:pharmacology; D000431:Ethanol / Q000096:biosynthesis; D006868:Hydrolysis; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008614:Meperidine / Q000009:adverse effects / Q000378:metabolism*; D008745:Methylation; D008862:Microsomes, Liver / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D013223:Statistics as Topic; D013237:Stereoisomerism; D014191:Tranylcypromine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D000431:Ethanol; D008614:Meperidine; D010293:Pargyline; D011335:Proadifen; D000661:Amphetamine; D007490:Iproniazid; D010624:Phenelzine; D003913:Dextroamphetamine